Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme


Collapse Biography 

Collapse Overview 
Collapse abstract
Project Summary Craniofacial development is a complex morphogenetic process, disruptions in which result in highly prevalent human birth defects. Signaling through the platelet-derived growth factor receptors (PDGFRs) plays a critical role in this process in humans and mice. Pdgfra mutant mouse models display a range of craniofacial phenotypes such as midline clefting, subepidermal blebbing and hemorrhaging. PDGFRa signaling promotes migration of cranial neural crest cells (NCCs), proliferation of the NCC-derived craniofacial mesenchyme and osteoblast differentiation. Recently, a role for PDGFRb has been uncovered in murine craniofacial development, as ablation of Pdgfrb in the NCC lineage results in increased nasal septum width, delayed palatal shelf development and subepidermal blebbing. Further, PDGFRa and PDGFRb have recently been shown to genetically and physically interact in the craniofacial mesenchyme to form functional heterodimers. These PDGFRa/b heterodimers have unique signal molecule binding properties and the ability to generate more robust intracellular signaling and mitogenic responses in vitro than those generated by homodimeric receptor complexes. Combined, these findings have shifted the paradigm on how receptor tyrosine kinases act to regulate craniofacial morphogenesis and warrant a full reconsideration of PDGF signaling in midface development. The aim of this proposal is to examine the in vivo dynamics of PDGFR dimer-specific formation, as well as the resulting effects on gene expression and cell activity in the craniofacial mesenchyme. First, PDGFR-bimolecular fluorescence complementation (BiFC) fragment alleles will be generated containing the N- or C-terminal regions of the Venus fluorescent protein. Venus expression will be analyzed in craniofacial structures by fluorescence microscopy to examine the spatiotemporal dynamics of PDGFR homodimer versus heterodimer formation. These alleles will be combined with ectoderm-specific ablation of PDGF-BB ligand to examine the effect on heterodimer formation. Second, the effect of SHP-2 binding to PDGFRa on downstream signaling will be determined through genetic epistasis experiments and, in parallel, BiFC and affinity purification will be employed to selectively purify PDGFRa/b heterodimers and identify PDGFR dimer-specific interacting proteins by mass spectrometry. Finally, RNA-sequencing will be performed to define the transcriptional program induced downstream of PDGFR dimer-specific activation in the maxillary processes. Transcriptional responses involved in proliferation and osteoblast differentiation will be validated through in vivo marker expression analysis to dissect the etiology of the midline defects observed upon ablation of one or both PDGFRs in the NCC lineage. This project will employ innovative techniques to pinpoint the timing and localization of PDGFR dimer-specific activation and analyze the resulting effects on the proteome and transcriptome. These studies will provide significant insight into the mechanisms underlying midface development and new therapeutic directions for the treatment of human craniofacial birth defects.
Collapse sponsor award id
R01DE027689

Collapse Time 
Collapse start date
2018-03-02
Collapse end date
2023-01-31

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)